<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03379285</url>
  </required_header>
  <id_info>
    <org_study_id>HDréa</org_study_id>
    <nct_id>NCT03379285</nct_id>
  </id_info>
  <brief_title>Management of Digestive Haemorrhaging In CHRU of Brest During 2009 and 2014</brief_title>
  <acronym>HDréa</acronym>
  <official_title>Risk Factors for Further Bleeding in Patients Admitted to Intensive Care for Gastro Intestinal Bleeding</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gastro intestinal (GI) bleeding is relatively frequent and may lead to intensive care unit
      admission. Although a restrictive strategy for red blood cell transfusion is supported by a
      large randomized controlled trial literature, less is known about the impact of transfusion
      strategy of other blood components and administration of anti fibrinolytic on clinical
      outcomes.

      This study aims to identify parameters that may be associated with the risk of further
      bleeding in patients admitted to ICU for GI bleeding.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 3, 2016</start_date>
  <completion_date type="Actual">December 31, 2016</completion_date>
  <primary_completion_date type="Actual">December 31, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Bleeding</measure>
    <time_frame>within a week</time_frame>
    <description>Bleeding persistance or recidive requiring an intervention or a scope</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>mortality</measure>
    <time_frame>during hospitalisation (28 days)</time_frame>
    <description>hospital mortality</description>
  </secondary_outcome>
  <enrollment type="Actual">272</enrollment>
  <condition>Gastro Intestinal Bleeding</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted to intensive care unit with the primary admission diagnosis of Gastro
        Intestinal Bleeding and who were not retrieved from another hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Gastro Intestinal Bleeding admitted to either medical or surgical
             intensive care unit

        Exclusion Criteria:

          -  patients retrieved from another hospital

          -  age &lt; 18 years consent withdrawal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHRU de Brest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2017</study_first_submitted>
  <study_first_submitted_qc>December 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 20, 2017</study_first_posted>
  <last_update_submitted>December 15, 2017</last_update_submitted>
  <last_update_submitted_qc>December 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gastro Intestinal Bleeding;</keyword>
  <keyword>Transfusion,</keyword>
  <keyword>Outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

